Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in pfizer

Pfizer Bolsters Cancer Portfolio With $10.64 Billion Deal For Array

Under new Chief Executive Officer Albert Bourla, Pfizer has been exploring ways to diversify its pipeline as its blockbuster pain drug Lyrica loses patent protection.

Read More

Pfizer Expects Broad Interest For Consumer Health Business

Pfizer Inc, the largest U.S. drugmaker, expects no shortage of suitors for its consumer health business and said it would decide whether to sell, spin off or retain the unit next year.

Read More

Pfizer Posts Rs 60.5 Crore Net Profit In December Quarter

Revenue for the quarter ended December 31, 2016 was Rs 504 crore as compared to Rs 521 crore in the same period last year

Read More

Pfizer Boosts Cancer Drug Roster With $14 Billion Medivation Deal

The planned purchase of Medivation, with its $2.2 billion-a-year Xtandi, is the latest in a number of deals by large drugmakers willing to pay top dollar for cancer drugs that are more effective than standard, older treatments

Read More

Pfizer Beats Estimates, But Branded Drugs Disappoint

Sales of generic medicines rose 16 percent to $6.04 billion, helped by Pfizer's $16 billion purchase last year of generic hospital products company Hospira

Read More

Cipla, Wockhardt And Pfizer Among Top Winners At DigiPharmaX 2016

The awards recognise the excellence in Digital in the Pharma industry and is the country's first award of this kind

Read More

Pfizer Approaches Medivation About Potential Takeover

Pfizer's approach comes less than a week after Sanofi went public with its $52.50 per share cash offer, complaining that Medivation refused to engage.

Read More

Investors Stick With Pfizer CEO After Allergan Deal Collapse

In 2014, Pfizer failed in its unsolicited $118 billion bid to buy London-based drugmaker AstraZeneca Plc after that deal ran into staunch opposition from British politicians

Read More

Atul: Formulating Success

Atul is an integrated chemical company with about 5,700 customers belonging to 31 industries across the world.

Read More

Pfizer, Allergan Scrap $160 Billion Deal After US Tax Rule Change

US drugmaker Pfizer Inc and Ireland-based Allergan Plc walked away from their $160 billion merger on Wednesday, a major win for President Barack Obama, who has been pushing to curb deals in which companies move overseas to save on taxes

Read More

Obama's Inversion Curbs Kill Pfizer's $160 Billion Allergan Deal

Pfizer will have to pay Allergan up to $400 million for its expenses as a result of terminating the deal, according to their merger agreement

Read More

Vicks Action 500 Extra, Phensedyl Sales To Resume

Many companies have approached the court challenging a decision by the Health Ministry to ban over 340 fixed dose combination drugs

Read More

Pfizer Stops Selling Popular Corex Cough Syrup In India After Ban

US pharmaceutical giant Pfizer Inc's India unit said on Monday it had stopped selling its popular Corex cough syrup, after regulators banned it saying it was likely to pose a risk to humans

Read More

India Bans More Than 300 Combination Drugs Sold Illegally

In 2014, India set up a committee to review more than 6,000 combinations that had entered the market based only on state regulators' approval

Read More

Medecins Sans Frontieres Files To Block Pfizer Patent On Pneumonia Vaccine In India

If government granted Pfizer a patent on its Prevnar 13 pneumonia vaccine, Indian firms would not be able to produce affordable versions of it for domestic use or exports

Read More